I recently finished my PhD as a Gates Cambridge Scholar, and am the recipient of the Angharad Dodds John Bursary in Mental Health and Neuropsychiatry for 2020-2021. I am also an MD candidate in the United States.
Much of my work has centred on the neurochemical modulation of affective and behavioural control, with a special emphasis on serotonin. I seek to connect pharmacological challenge studies with deficits in psychiatric disorders, with a particular interest in obsessive-compulsive disorder (OCD). I am comparing deficits in behavioural flexibility across compulsive disorders with the goal of informing the refinement of psychiatric classification and treatment. I am also interested in the possibility of revising maladaptive associations by harnessing the process of memory reconsolidation or through the use of psychedelic drugs.
Associated News Items
Kanen JW, Arntz FE, Yellowlees R, Cardinal RN, Price A, Christmas DM, Apergis-Schoute AM, Sahakian BJ, Robbins TW (in press), “Serotonin depletion amplifies distinct human social emotions as a function of individual differences in personality” Translational Psychiatry
Kanen JW, Arntz FE, Yellowlees R, Christmas DM, Price A, Apergis-Schoute AM, Sahakian BJ, Cardinal RN, Robbins TW (2021), “Effect of tryptophan depletion on conditioned threat memory expression: role of intolerance of uncertainty” Biological Psychiatry: CNNI
Kanen JW, Apergis-Schoute AM, Yellowlees R, Arntz FE, van der Flier FE, Price A, Cardinal RN, Christmas DM, Clark L, Sahakian BJ, Crockett MJ, Robbins TW (2020), “Serotonin depletion impairs both Pavlovian and instrumental reversal learning in healthy humans” bioRxiv
Kanen JW, Arntz FE, Yellowlees R, Cardinal RN, Price A, Christmas DM, Sahakian BJ, Apergis-Schoute AM, Robbins TW (2020), “Probabilistic reversal learning under acute tryptophan depletion in healthy humans: a conventional analysis” Journal of Psychopharmacology
Kanen JW, Luo Q, Kandroodi M, Cardinal RN, Robbins TW, Carhart-Harris RL, den Ouden HEM (2020), “Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans” bioRxiv
Luo Q, Zhang L, Huang C-C, Zheng Y, Kanen JW, Zhao Q, Yao Y, Quinlan EB, Jia T, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Flor H,11, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot J-L, Martinot M-LP, Nees F, Orfanos DP, Poustka L, Hohmann S, Fröhner JH, Smolka MN, Walter H, Whelan R, Sahakian BJ, Schumann G, Li F, Feng J, Desrivières S, Robbins TW and the IMAGEN consortium (2020), “Association between childhood trauma and risk for obesity: a putative neurocognitive developmental pathway” BMC Medicine
Kanen JW, Ersche KD, Fineberg NA, Robbins TW, Cardinal RN (2019), “Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents” Psychopharmacology
de Voogd LD, Kanen JW, Neville DA, Roelofs K, Fernández G, Hermans EJ (2018), “Eye-Movement Intervention Enhances Extinction via Amygdala Deactivation” Journal of Neuroscience
Hermans EJ, Kanen JW, Tambini A, Fernández G, Davachi L, Phelps EA (2017), “Persistence of amygdala-hippocampal connectivity and multi-voxel correlation structures during awake rest after fear learning predicts long-term expression of fear” Cerebral Cortex
Kanen JW, Nazir R, Sedky K, Pradhan, B (2015), “The effects of mindfulness-based interventions on sleep disturbance: a meta-analysis” Adolescent Psychiatry
Steinfurth ECK, Kanen JW, Raio CM, Clem R, Huganir R, Phelps EA (2014), “Recent and remote Pavlovian fear memories can be modified with extinction training during reconsolidation in humans” Learning & Memory
Schiller D, Kanen JW, LeDoux JE, Monfils MH, Phelps EA (2013), “Extinction during reconsolidation of threat memory diminishes prefrontal cortex involvement” Proceedings of the National Academy of Sciences